- Launched the Global Plan to End TB and the 90-(90)-90 targets
- Secured Heads of States’ commitment to increase TB financing and achieve the 90-(90)-90 targets
- Chair of the Board launched and led successful campaign for a UN HLM on TB
- G20 Heads of State recognized TB as a key priority and G20 Health Ministers recognized the lead role of the Stop TB Partnership
Between 2001 and 2017:
- Delivered 29.7 million adult TB treatments, 1.8 million pediatric TB treatments, 258,006 treatments for drug-resistant TB
- Procured TB diagnostics worth US$ 173 million for more than 93 countries
- Ensured bedaquiline, delamanid and new pediatric formulations are available, as well as a stable and competitive supplier base
Between 2010 and 2016:
- Provided 180 grants in 48 countries for US$ 111 million
- TB REACH grantees, working in close collaboration with national TB programmes, diagnosed and treated over 2 million people with TB, saving 900,000 lives in the most underserved populations
- Informed the development of global guidance on TB detection and care through in-country experiences
Between 2007 and 2017:
- Through Challenge Facility for Civil Society, awarded 131 grants via seven rounds of funding, strengthening grassroots community systems
- Developed and implemented a TB Gender Assessment Tool, 10 Key Population Guides, a Legal Environment Assessment Tool and a TB Law Case Compendium
- Strengthened TB Survivor Networks through four regional and 56 national networks of people affected by TB
- Training and implementation of the TB/HIV Gender Assessment Tool, the Legal Environment Assessment Tool and the Action Framework for Key, Vulnerable and Underserved Populations is underway and being rolled out in several high-burden countries
